Influencing Factors of Transient Elastography in Detecting Liver Stiffness

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2016 Oct 5

PMID 27698728

Citations 5

Authors

Rong Shan

Hong Yin

Wenjuan Yang

Jianzhi Li

Meifang Zhang

Min Zhao

Jiang Shao

Aiguang Wang

Affiliations

Soon will be listed here.

Abstract

Liver stiffness, which correlates well with liver fibrosis stage, can be measured noninvasively by transient elastography, also known as Fibroscan. The present study aimed to determine the independent factors influencing Fibroscan detection by multiple regression analysis. A total of 181 patients who required liver biopsy were enrolled. Liver stiffness measurement (LSM) was detected by Fibroscan on the day of liver biopsy, while clinical information and routine biochemical examination results were also collected. Correlation was analyzed by Spearman's correlation, and multiple regression analysis was performed to analyze the independent influencing factors. The results demonstrated that platelet (PLT) levels, serum albumin (ALB), prothrombin activity (PTA) and body mass index (BMI) were independent predictors of liver stiffness. The contribution of these four predictors to the regression equation was in the following descending order: PLT (negative correlation) > ALB (negative correlation) > PTA (negative correlation) > BMI (positive correlation). In conclusion, the parameters of PLT, ALB, PTA and BMI are independent predicting factors affecting Fibroscan detection. Therefore, the diagnosis and evaluation of liver fibrosis should comprehensively consider the results of Fibroscan, and clinical and laboratory examinations.

Citing Articles

A J-shaped relationship between body mass index and the risk of elevated liver stiffness: a cross-sectional study.

Liu Y, Yuan S, Zuo J, Liu S, Tang X, Li X Eur J Med Res. 2023; 28(1):557.

PMID: 38049896 PMC: 10696772. DOI: 10.1186/s40001-023-01543-3.

Prevalence and Determinants of Undiagnosed Liver Steatosis and Fibrosis in a Nationally Representative Sample of US Adults.

Bhattacharyya M, Nickols-Richardson S, Miller A, Bhattacharyya R, Frankhauser F, Miller L Cureus. 2023; 15(10):e46783.

PMID: 37954822 PMC: 10633855. DOI: 10.7759/cureus.46783.

Which factors influence liver stiffness measured by real-time two dimensional shear wave elastography in patients on maintenance hemodialysis?.

Zjacic Puljiz D, Delic Jukic I, Puljiz M, Vicelic cutura L, Jercic Martinic-Ceza I, Bozic D Croat Med J. 2021; 62(1):34-43.

PMID: 33660959 PMC: 7976885.

Liver stiffness measurement predicts the difficulty of Kasai procedure in biliary atresia: a single center retrospective analysis of 199 patients.

Shen Q, Chen Y, Peng C, Pang W, Wang Z, Wu D BMC Pediatr. 2019; 19(1):465.

PMID: 31779592 PMC: 6883583. DOI: 10.1186/s12887-019-1846-3.

Transient Elastography for Detection of Liver Fibrosis in Children With Autosomal Recessive Polycystic Kidney Disease.

Wicher D, Jankowska I, Lipinski P, Szymanska-Rozek P, Kmiotek J, Janczyk W Front Pediatr. 2019; 6:422.

PMID: 30687687 PMC: 6336693. DOI: 10.3389/fped.2018.00422.

References

Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X . Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2005; 55(3):403-8. PMC: 1856085. DOI: 10.1136/gut.2005.069153. View

Chen J, Eslick G, Weltman M . Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly. Aliment Pharmacol Ther. 2013; 39(2):117-24. DOI: 10.1111/apt.12563. View

Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann F, Pritsch M . Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010; 16(8):966-72. PMC: 2828601. DOI: 10.3748/wjg.v16.i8.966. View

Lu S, Wang J, Liu S, Hung C, Chen C, Tung H . Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer. 2006; 107(9):2212-22. DOI: 10.1002/cncr.22242. View

Vergniol J, Foucher J, Mamou K, Castera L, Bernard P, Couzigou P . Non-invasive evaluation of liver fibrosis using FibroScan in long-term sustained-virological responder patients after HCV treatment. Gastroenterol Clin Biol. 2008; 32(12):1061-3. DOI: 10.1016/j.gcb.2008.09.018. View

Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M . Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128(2):343-50. DOI: 10.1053/j.gastro.2004.11.018. View

Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R . Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology. 2005; 42(4):838-45. DOI: 10.1002/hep.20814. View

Tapper E, Cohen E, Patel K, Bacon B, Gordon S, Lawitz E . Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2012; 10(8):932-937.e1. PMC: 3402604. DOI: 10.1016/j.cgh.2012.01.015. View

Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly J . Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther. 2008; 28(10):1188-98. DOI: 10.1111/j.1365-2036.2008.03831.x. View

10.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F . Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009; 27(47):6550-7. DOI: 10.1016/j.vaccine.2009.08.048. View

11.

Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O . Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol. 2008; 43(9):720-8. DOI: 10.1007/s00535-008-2225-2. View

12.

Wang J, Changchien C, Hung C, Tung W, Kee K, Chen C . Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan. J Gastroenterol Hepatol. 2010; 25(5):964-9. DOI: 10.1111/j.1440-1746.2009.06194.x. View

13.

Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H . Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol. 2010; 53(6):1013-21. DOI: 10.1016/j.jhep.2010.05.035. View

14.

Bonder A, Afdhal N . Biopsy no more; changing the screening and diagnostic algorithm for hepatitis C. Clin Gastroenterol Hepatol. 2012; 11(3):309-10. DOI: 10.1016/j.cgh.2012.12.003. View

15.

Sharara A, Hunt C, Hamilton J . Hepatitis C. Ann Intern Med. 1996; 125(8):658-68. DOI: 10.7326/0003-4819-125-8-199610150-00006. View

16.

Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T . Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009; 49(6):1954-61. DOI: 10.1002/hep.22870. View

17.

Wright T, Lau J . Clinical aspects of hepatitis B virus infection. Lancet. 1993; 342(8883):1340-4. DOI: 10.1016/0140-6736(93)92250-w. View

18.

El-Serag H . Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001; 5(1):87-107, vi. DOI: 10.1016/s1089-3261(05)70155-0. View

19.

Aleman S, Rahbin N, Weiland O, Davidsdottir L, Hedenstierna M, Rose N . A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clin Infect Dis. 2013; 57(2):230-6. DOI: 10.1093/cid/cit234. View

20.

Tana M, Zhao X, Bradshaw A, Moon M, Page S, Turner T . Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res. 2015; 135(5):823-8. PMC: 4414791. DOI: 10.1016/j.thromres.2015.02.010. View